Piramal Group Stocks

Piramal Group is a multinational business conglomerate with a strong presence in financial services, pharma, and real estate. The Group has offices in

Piramal Group is a multinational business conglomerate with a strong presence in financial services, pharma, and real estate. The Group has offices in more than 30 countries and a brand presence in over 100 markets in the world. They operate with more than 10,000 people globally from 21 various nationalities.
In more than 30 years of its existence, Piramal Group has pursued a twin strategy of organic and inorganic growth. Piramal Group aims for inclusive growth while sticking to ethical and values-driven practices.

Company	LTP	Volume	Market Cap	52W High	52W Low	Sector

History of Piramal Group

The Piramal Group, led by Ajay Piramal since the early 1980s, has evolved into a global business conglomerate with a significant footprint in healthcare, life sciences, drug discovery, real estate, financial services, and glass packaging. Beginning with acquiring Gujarat Glass Limited in 1984 and Nicholas Laboratories in 1988, the group expanded through strategic acquisitions, including Roche's Indian subsidiary in 1993 and Ceylon Glass Company in 1999.

Notably, in 2010, Piramal Healthcare sold its domestic formulations business to Abbott for $3.72 billion, marking one of the most expensive deals in the pharmaceutical industry. The group has also ventured into real estate with Piramal Realty and made significant contributions to healthcare and contract manufacturing, earning a spot among the top corporations in India and globally.

Piramal Group’s Sector Presence

Piramal Group currently operates in sectors such as:

Financial Services: Through Piramal Enterprises Ltd, the Group provides financial services.
Pharma: Through Piramal Pharma Limited (PPL), the Group provides a wide range of products and services through end-to-end manufacturing facilities.
Real estate: Piramal Realty is the real estate development arm of the Piramal Group.

Key Personnel of the Piramal Group

Ajay Piramal, Chairman and Executive Director

Ajay Piramal is the Chairman of the Piramal Group. He is considered to be a torchbearer for responsible entrepreneurship. He holds important positions on the Boards of various companies and prestigious institutions. He serves on the Harvard Business School’s Board of Dean’s Advisors, Non-Executive Director of Tata Sons Ltd, and co-chair of the UK-India CEO Forum.

How To Invest in the Piramal Group Stocks?

Investing in Piramal Group stocks via Angel One is easy. Simply follow these steps:

Log in to your Angel One account.
Click on the search icon and look for your desired Piramal Group stock.
Now, place your buy order. Simply click on the ‘Buy’ button, enter your desired quantity, and select the order type.
To complete your transaction, click on the ‘Buy’ button.

If you don’t have a Demat account with Angel One, you can open one for free online within minutes.

FAQs

Which are the listed stocks of Piramal Group?

The listed stocks of Piramal Group are Piramal Enterprises Ltd and Piramal Pharma Ltd.

Which is the biggest Piramal Stock in terms of market cap?

As of January 20, 2024, the largest Piramal Group stock based on the market capitalisation is Piramal Enterprises Ltd. The market cap of the company is ₹20,021.33 crore.

Who is the founder of Piramal Group stocks?

The founder of Piramal Group is Ajay Piramal. He is also the Chairman and Executive Director of the Piramal Group.

Which Piramal Group stock is the highest profit-making company?

Piramal Enterprises Ltd earned a net income of ₹48.19 crore in the quarter that ended September 30, 2023, making it the highest profit-making company in the Piramal Group.

Which Piramal Group stock has the highest debt?

Piramal Enterprises Ltd has the highest debt in the Piramal Group stock, where the total debt is ₹49,582.81 crore as of January 20, 2024.

Piramal Group Stocks

Open Free Demat Account!